CDC Advises Docs to Inform Patients of Limitations of DTC Gene Scans
August 11, 2010
CDC Advises Docs to Inform Patients of Limitations of DTC Gene Scans
"The promise of genomics in the practice of medicine is great and exciting, but today the use of personal genomic tests is still not ready for prime time," a CDC official said in a video address to doctors and the general public.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- DTC Genomics Gets Time Before FDA as Agency Considers Regulatory Strategy
July 21, 2010 / Pharmacogenomics Reporter - Adding Alzheimer's Risk Option, 23andMe Revives Questions on Utility of DTC Genomics
April 20, 2011 / Pharmacogenomics Reporter - ASU Biodesign Scientists Hope to Apply Direct-to-Consumer Model to Proteomics Testing
February 4, 2011 / ProteoMonitor - FDA Tells Congress it is Mulling Strategies to Regulate DTC Genetic Tests as Medical Devices
July 28, 2010 / Pharmacogenomics Reporter - FDA's Gutierrez Provides Additional Clarity Regarding Oversight of DTC Genomics Firms
May 19, 2010 / Pharmacogenomics Reporter